Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

MEC Plus

Speciality

Author / Speaker

Title

Type of Media

Events

Search Everything

«
1
…
89
90
91
92
93
…
96
»

Managing Expectations – Goals of Care

Managing Expectations – Goals of Care

Robin B. Rome, MSN, FNP-ACHPN

The Entire Sepctrum of Her-2Management in Breast Cancer Disease - All Clinical Settings

The Entire Sepctrum of Her-2Management in Breast Cancer Disease - All Clinical Settings

Hope S. Rugo, MD

CLL - At Recurrence, What is the BestTherapy and What is Comingfrom the Bench Lab

CLL - At Recurrence, What is the BestTherapy and What is Comingfrom the Bench Lab

Nakhle Saba

RET, MET, & NTRK in Non-Small Cell Lung Cancer

RET, MET, & NTRK in Non-Small Cell Lung Cancer

Edgardo S. Santos, MD, FACP

B-Cell NHL and Hodgkin’s Disease

B-Cell NHL and Hodgkin’s Disease

Eduardo M. Sotomayor, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Martin S. Tallman, MD

ER-PR Breast Disease - Early Stage, LocallyAdvanced and Metastatic Breast Cancer

ER-PR Breast Disease - Early Stage, LocallyAdvanced and Metastatic Breast Cancer

Vicente Valero, MD, FACP

Squamous Cell Carcinoma

Squamous Cell Carcinoma

Antoinette J. Wozniak, MD, FACP, FASCO

Handling the Most Common Toxicitiesfrom IO - Endocrinopathies,Pneumonitis, Skin Rash Pruritus and Adrenal Insufficiency

Handling the Most Common Toxicitiesfrom IO - Endocrinopathies,Pneumonitis, Skin Rash Pruritus and Adrenal Insufficiency

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Immunotherapy in Melanoma Skin Cancers

Immunotherapy in Melanoma Skin Cancers

Sanjiv S. Agarwala, MD

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

Melissa Alsina, MD

Oncologic Emergencies The Oncology Nurse Role

Oncologic Emergencies The Oncology Nurse Role

Erica Corcoran, MSN, RN, OCN, AOCNS, ONN-CG

Novel Applications of SRS in Oncology-Clinical Cases

Novel Applications of SRS in Oncology-Clinical Cases

Beatriz Amendola, MD, FACR, FACRO, FASTRO

Colorectal Cancer - What’s New

Colorectal Cancer - What’s New

Luis Baez Vallecillo, MD

Advances In The Treatment of Gynecologic Malignancies

Advances In The Treatment of Gynecologic Malignancies

Gerardo Colon-Otero, MD

Double Hit Lymphomas

Double Hit Lymphomas

William Caceres-Perkins, MD, FACP

Management of Most Common Toxicities Seen with Checkpoint Inhibitors

Management of Most Common Toxicities Seen with Checkpoint Inhibitors

Mildred Flores, PhD

Surgical Approaches of Metastatic Colorectal Cancers

Surgical Approaches of Metastatic Colorectal Cancers

Dido Francheschi, MD

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Thomas J. Herzog, MD

Immunotherapy in Kidney and Bladder Cancers

Immunotherapy in Kidney and Bladder Cancers

Michael E. Hurwitz, MD, PhD

Pancreas and Hepatobiliary Tract

Pancreas and Hepatobiliary Tract

George P. Kim, MD

Neoadjuvant and Adjuvant Therapies for Esophageal and Gastric Cancers

Neoadjuvant and Adjuvant Therapies for Esophageal and Gastric Cancers

José Lozada, M.D

HER-2 Disease - Neo-, Adjuvant, Metastatic settings

HER-2 Disease - Neo-, Adjuvant, Metastatic settings

Shanu Modi, MD

Modern Antiemetics during Cancer Therapy

Modern Antiemetics during Cancer Therapy

Jessica MacIntyre, ARNP, NP-C, AOCNP

Triple Negative Breast Cancer - Still Jurasic Park

Triple Negative Breast Cancer - Still Jurasic Park

Noridza Rivera-Rodriguez, MD

Liquid Biopsy in Oncology

Liquid Biopsy in Oncology

Christian Rolfo, MD, PhD, MBA, Dr.h.c.

New Landscape of Mutant EGFR & ALK Lung Cancer Patients

New Landscape of Mutant EGFR & ALK Lung Cancer Patients

Edgardo S. Santos, MD, FACP

CAR-T Cell in Oncology

CAR-T Cell in Oncology

Eduardo M. Sotomayor, MD

Other Driver Mutations in Lung Cancer - RET,ERBB2, MET, NTRK

Other Driver Mutations in Lung Cancer - RET,ERBB2, MET, NTRK

Tom Stinchcombe

How to Monitor and Management Complications from Direct Thrombin Inhibitors

How to Monitor and Management Complications from Direct Thrombin Inhibitors

ADALBERTO TORRES-HERNÁNDEZ

Displaying 2,701 - 2,730 of 2,875

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Useful Links

Library
Live Events

Categories

MEC Basic
MEC Plus
Purchased

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok